Gynecological cancers, such as endometrial and ovarian cancers, pose significant threats to women’s health. Globally, endometrial and ovarian cancers account for over 420,000 and 320,000 new cases annually, respectively, with high mortality rates[1]. In the United States, an estimated 69,120 uterine corpus and 20,890 ovarian cancer cases will be diagnosed in 2025, leading to approximately […]